Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.255 USD | +1.19% | -20.56% | -87.56% |
15/04 | Ampio Pharmaceuticals, Inc.(NYSEAM:AMPE) dropped from S&P TMI Index | CI |
27/03 | Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 6
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Martino
CEO | Chief Executive Officer | 68 | 13/21/13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Stevens
BRD | Director/Board Member | 75 | 01/11/01 |
J. Buchi
CHM | Chairman | 69 | 13/21/13 |
Michael Martino
CEO | Chief Executive Officer | 68 | 13/21/13 |
Elizabeth Jobes
BRD | Director/Board Member | 57 | 08/22/08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,135,358 | 1,117,631 ( 98.44 %) | 0 | 98.44 % |
Company contact information
Ampio Pharmaceuticals, Inc.
9800 Mount Pyramid Court Suite 400
80112, Englewood
+720 437 6500
http://www.ampiopharma.comSector
1st Jan change | Capi. | |
---|---|---|
-87.56% | 290K | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- AMPE Stock
- Company Ampio Pharmaceuticals, Inc.